Sponsors (22)
The bill accelerates VA access to FDA‑cleared non‑opioid pain treatments—improving pain care and reducing opioid reliance for veterans—but increases fiscal pressure, limits a specified funding source, and imposes a tight implementation timeline that may strain VA operations.
Veterans gain faster access to FDA‑cleared non‑opioid pain drugs and biologics, expanding non‑opioid options for postoperative and acute pain and reducing reliance on opioids.
Provides a predictable, mandatory timeline for VA adoption of new therapies, helping VA pharmacies and clinicians plan procurement, inventory, and patient treatment pathways.
Mandating addition of new, potentially high‑cost drugs to the VA formulary may increase VA drug spending and put pressure on VA budgets, with costs ultimately borne by taxpayers or forcing tradeoffs in other services.
The bill prohibits use of the Cost of War Toxic Exposures Fund to implement these changes, reducing funding flexibility and potentially shifting expenses onto other VA accounts or programs.
A short 90‑day implementation deadline could create administrative strain for the VA, risking implementation errors, supply‑chain disruptions, or logistics challenges for hospitals and clinics delivering care.
Based on analysis of 2 sections of legislative text.
Requires the VA to add FDA-approved non-opioid pain drugs/biologics to its national formulary within set deadlines tied to Medicare payment eligibility or FDA approval and forbids using a toxic exposures fund to pay for it.
Introduced November 19, 2025 by Shelley Moore Capito · Last progress November 19, 2025
Requires the Department of Veterans Affairs to add FDA-approved or cleared non-opioid pain management drugs and biological products to the VA national formulary on a fast timetable tied to CMS payment eligibility or FDA approval. It defines “non-opioid pain management drug or biological product,” bars use of the Cost of War Toxic Exposures Fund to carry out the policy, and directs the VA Secretary to implement the change within 90 days of enactment.